Franz H Messerli Selected Research

Verapamil (Calan)

1/2016	Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy.
1/2015	Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.
8/2014	2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.
3/2014	Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.
8/2010	Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.
6/2009	Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
4/2009	Characteristics and outcomes of revascularized patients with hypertension: an international verapamil SR-trandolapril substudy.
8/2008	Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
2/2008	Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.
10/2007	Obesity paradox in patients with hypertension and coronary artery disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franz H Messerli Research Topics

Disease

87	Hypertension (High Blood Pressure) 01/2022 - 06/2002
34	Stroke (Strokes) 01/2018 - 02/2003
28	Myocardial Infarction 09/2020 - 10/2003
22	Heart Failure 01/2019 - 12/2003
19	Coronary Artery Disease (Coronary Atherosclerosis) 10/2019 - 12/2003
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2003
10	Diabetes Mellitus 02/2016 - 01/2004
8	Edema (Dropsy) 10/2019 - 06/2002
6	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2016 - 11/2002
6	Type 2 Diabetes Mellitus (MODY) 12/2013 - 11/2004
5	Angioedema 01/2018 - 06/2008
5	Coronary Disease (Coronary Heart Disease) 01/2017 - 11/2003
5	Angina Pectoris 02/2016 - 07/2004
4	COVID-19 01/2021 - 01/2020
4	Isolated Systolic Hypertension 12/2016 - 02/2003
4	Essential Hypertension 05/2016 - 07/2003
4	Neoplasms (Cancer) 04/2013 - 06/2002
3	Renal Insufficiency (Renal Failure) 02/2017 - 01/2012
3	Proteinuria 01/2016 - 09/2010
3	Hypotension (Low Blood Pressure) 05/2013 - 02/2009
3	Hyperkalemia 05/2013 - 02/2009
3	Hypercholesterolemia 01/2013 - 10/2004
2	Pre-Eclampsia (Preeclampsia) 10/2021 - 01/2019
2	Body Weight (Weight, Body) 01/2019 - 01/2017
2	Infarction (Infarctions) 01/2019 - 07/2014
2	Heart Diseases (Heart Disease) 11/2018 - 02/2007
2	Cough 01/2018 - 11/2010
2	Acute Coronary Syndrome 11/2017 - 09/2015
2	Hemorrhage 11/2017 - 09/2015
2	Renal Artery Obstruction (Renal Artery Stenosis) 01/2016 - 05/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2012 - 11/2003
2	Dementia (Dementias) 09/2010 - 03/2007
2	Albuminuria 09/2010 - 02/2009
2	Insulin Resistance 01/2008 - 11/2004
2	Vascular Diseases (Vascular Disease) 10/2006 - 04/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2005 - 06/2002
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2004 - 01/2004
1	Acute fatty liver of pregnancy 10/2021
1	HELLP Syndrome 10/2021
1	Hemolysis 10/2021
1	Pregnancy Complications 10/2021
1	Noncommunicable Diseases 01/2021

Drug/Important Bio-Agent (IBA)

40	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 06/2002
23	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 06/2002
17	Angiotensin Receptor AntagonistsIBA 01/2020 - 11/2002
16	Pharmaceutical PreparationsIBA 10/2019 - 11/2003
16	CalciumIBA 04/2009 - 06/2002
15	DiureticsIBA 01/2020 - 06/2002
15	Verapamil (Calan)FDA LinkGeneric 01/2016 - 07/2004
14	Atenolol (Tenormin)FDA LinkGeneric 01/2016 - 06/2002
14	trandolapril (Mavik)FDA LinkGeneric 01/2016 - 12/2003
9	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018 - 11/2002
8	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2020 - 12/2003
7	Biomarkers (Surrogate Marker)IBA 10/2021 - 11/2002
6	1,4-dihydropyridine (dihydropyridine)IBA 02/2013 - 11/2002
6	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2013 - 03/2005
5	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2022 - 11/2003
5	Amlodipine (Norvasc)FDA LinkGeneric 10/2019 - 06/2002
4	SaltsIBA 01/2020 - 05/2012
4	Chlorthalidone (Chlortalidone)FDA LinkGeneric 01/2020 - 11/2003
4	LDL CholesterolIBA 02/2017 - 10/2006
4	Atorvastatin (Lipitor)FDA Link 01/2017 - 08/2006
4	LipidsIBA 01/2017 - 11/2003
4	Metoprolol (Toprol-XL)FDA LinkGeneric 07/2014 - 11/2004
4	Carvedilol (Coreg)FDA LinkGeneric 01/2008 - 05/2004
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 09/2015
3	AngiotensinsIBA 01/2020 - 01/2005
3	IvabradineIBA 01/2019 - 01/2016
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 02/2008
3	ThiazidesIBA 03/2015 - 11/2003
3	antineoplaston A10 (A 10)IBA 06/2011 - 05/2010
3	DihydropyridinesIBA 04/2009 - 07/2002
3	Angiotensin IIIBA 08/2007 - 04/2004
3	Losartan (Cozaar)FDA LinkGeneric 04/2004 - 11/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2021 - 01/2019
2	Tyrosine (L-Tyrosine)FDA Link 10/2021 - 01/2019
2	SodiumIBA 01/2021 - 01/2020
2	Dietary SodiumIBA 01/2021 - 01/2020
2	ReninIBA 01/2020 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2019 - 01/2013
2	Uric Acid (Urate)IBA 01/2019 - 05/2016
2	CholesterolIBA 01/2019 - 01/2016
2	oxidized low density lipoproteinIBA 02/2017 - 04/2015
2	Trinitrotoluene (TNT)IBA 04/2015 - 07/2014
2	Mineralocorticoid Receptor AntagonistsIBA 05/2013 - 01/2008
2	PotassiumIBA 12/2011 - 01/2008
2	Glucose (Dextrose)FDA LinkGeneric 06/2011 - 07/2006
2	CreatinineIBA 09/2010 - 02/2009
2	lercanidipineIBA 11/2002 - 07/2002
1	EnzymesIBA 10/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2021
1	ML 9IBA 10/2021
1	MB Form Creatine KinaseIBA 09/2020

Therapy/Procedure

47	Therapeutics 01/2021 - 06/2002
4	Denervation 01/2021 - 12/2013
3	Percutaneous Coronary Intervention 11/2017 - 10/2007
3	Secondary Prevention 02/2017 - 01/2012
2	Stents 11/2017 - 04/2008
2	Drug Therapy (Chemotherapy) 08/2014 - 02/2003
2	Glycemic Control 01/2008 - 11/2004